Hot Stock List: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), eLong Inc. (NASDAQ:LONG), Pool Corp. (NASDAQ:POOL), NewLink Genetics Corporation (NASDAQ:NLNK), Williams Partners L.P. (NYSE:WPZ)

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) will announce second quarter 2015 financial results on Tuesday, August 11, 2015. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) belongs to Healthcare sector. Its weekly performance is -2.34%. On last trading day company shares ended up $0.63. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) distance from 50-day simple moving average (SMA50) is -15.61%.

eLong, Inc. (Nasdaq: LONG), reported unaudited financial results for the second quarter ended June 30, 2015. Accommodation reservation[1] room nights stayed in the second quarter increased 36% to 11.4 million room nights compared to 8.3 million in the prior year period. Gross revenue earned from accommodation reservation (Non-GAAP)[2] reached RMB363 million, increasing 10% in the second quarter of 2015 compared to the same period in 2014. eLong Inc. (NASDAQ:LONG) shares advanced 20.25% in last trading session and ended the day at $17.10. LONG Gross Margin is 58.70% and its return on assets is -15.50%. eLong Inc. (NASDAQ:LONG) quarterly performance is 2.83%.

Pool Corp. (NASDAQ:POOL) announced that its Board of Directors declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on August 26, 2015 to holders of record on August 12, 2015. On 04 August, Pool Corp. (NASDAQ:POOL) shares advanced 0.13% and was closed at $70.77. POOL EPS growth in last 5 year was 44.30%. Pool Corp. (NASDAQ:POOL) year to date (YTD) performance is 12.34%.

Ames-based NewLink Genetics Corporation (NASDAQ:NLNK) announced that interim data suggests the VSV-EBOV (Ebola) vaccine candidate is effective in a large clinical trial in Guinea.According to the data, the vaccine candidate demonstrates efficacy within 10 days of administration to a patient with the infection. The development of this vaccine has been a five-year process, and after all this time, NewLink Chief Executive Officer and Chief Scientific Officer Dr. Charles Link feels that the results are telling of all the work that has gone into this project. NewLink Genetics Corporation (NASDAQ:NLNK) ended the last trading day at $51.83. Company weekly volatility is calculated as 5.48% and price to cash ratio as 6.91. NewLink Genetics Corporation (NASDAQ:NLNK) showed a weekly performance of -3.68%.

Williams Partners L.P. (NYSE:WPZ) reported weaker-than-expected second quarter results. Units of Williams have fallen over 4% since the earnings miss. The partnership announced earnings of 14 cents per limited-partner unit, missing the Zacks Consensus Estimate of 21 cents. However, the bottom line improved from the year-ago profit level of 11 cents. Williams Partners L.P. (NYSE:WPZ) shares fell -4.48% in last trading session and ended the day at $43.47. Its return on assets is 0.20%. Williams Partners L.P. (NYSE:WPZ) quarterly performance is -10.63%.

Leave a Reply

Your email address will not be published. Required fields are marked *